Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a prostate cancer early-detection programme funded by Yorkshire Cancer Research.

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...

Getting a timely scan within 48 hours for accident and emergency patients with blood in urine (hematuria) speeds up bladder cancer diagnosis and significantly saves lives.

Let's see what is getting investors excited today. The post Why is this ASX 300 stock rocketing 17% today? appeared first on The Motley Fool Australia.

A North Carolina man’s life‑changing prostate cancer diagnosis is opening doors to conversations on men’s health.

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Himisha Beltran discussing how to read a ...

Men with aggressive prostate cancer, often left with few options after chemotherapy fails, now have access to a new treatment that uses a radioactive substance.The new treatment, Lutetium-177 PSMA ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...